Since July 2016, Apple has been in discussions with the FDA about two FDA-regulated products in the cardiac monitoring space, MobiHealthNews has learned. The revelation comes from a collection of emails MobiHealthNews obtained via a Freedom of Information Act request to the FDA.
On July 14, 2016, Robin Goldstein, at the time Principal Counsel for Apple, sent an email to FDA Associate Center...
